Home › Funds › BI Asset Management Fondsmaeglerselskab A/S › JNJ

BI Asset Management Fondsmaeglerselskab A/S position in JNJ

JOHNSON & JOHNSON · Health Care

BI Asset Management Fondsmaeglerselskab A/S reported holding 340,171 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$89.9M, representing 0.68% of its reported portfolio and ranking #21 among its reported holdings. BI Asset Management Fondsmaeglerselskab A/S has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)340.17K sh
Reported value held$89.88M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BI Asset Management Fondsmaeglerselskab A/S's JNJ position evolved

BI Asset Management Fondsmaeglerselskab A/S first disclosed a stake in JNJ in Q3 2023 at 178,797 shares (US$27.8M). The position peaked in Q2 2026 at 488,378 shares, worth US$123.9M. Across 13 filings, BI Asset Management Fondsmaeglerselskab A/S increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 340,171 shares valued at US$89.9M — a reduction of -148,207 shares quarter over quarter.. Notable position changes include a 59% increase in Q4 2023 (shares rose 1% over the following quarter), a 26% increase in Q3 2025 (shares rose 11% over the following quarter), a 30% trim in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 178.80K $27.85M New
Q4 2023 284.21K $44.55M Add
Q1 2024 341.75K $54.06M Add
Q2 2024 338.81K $49.52M Reduce
Q3 2024 328.41K $53.22M Reduce
Q4 2024 382.09K $55.26M Add
Q1 2025 417.07K $69.17M Add
Q2 2025 327.16K $49.97M Reduce
Q3 2025 411.51K $76.30M Add
Q4 2025 452.59K $93.66M Add
Q1 2026 396.16K $96.67M Reduce
Q2 2026 488.38K $123.86M Add
Q3 2026 340.17K $89.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BI Asset Management Fondsmaeglerselskab A/S held JNJ?

BI Asset Management Fondsmaeglerselskab A/S has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BI Asset Management Fondsmaeglerselskab A/S's current position in JNJ?

As of Q3 2026, BI Asset Management Fondsmaeglerselskab A/S holds 340.17K shares of JNJ (JOHNSON & JOHNSON), valued at $89.88M, representing 0.68% of its reported portfolio and ranking #21.

Has BI Asset Management Fondsmaeglerselskab A/S been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BI Asset Management Fondsmaeglerselskab A/S reduced its position in JNJ. The position peaked in Q2 2026 at 488.38K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.